I. Matsumura

M. Kudo, I. Matsumura, T. Okuno, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.

S. Fujiwara, S. Kimura, Y. Kanda, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial.

S. Fujiwara, S. Kimura, Y. Kanda, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group

I. Matsumura, Y. Miyazaki, H. Kiyoi, 2020, International Journal of Hematology.

NF-kappaB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species.

T. Era, I. Matsumura, J. Ishikawa, 2004, The Journal of biological chemistry.

Successful allogeneic hematopoietic stem cell transplantation in a young patient with Richter syndrome presenting with chronic lymphocytic leukemia and diffuse large B-cell lymphoma with different cell origins.

I. Matsumura, Yasuyoshi Morita, Shinya Rai, 2013, Internal medicine.

Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia

I. Matsumura, Yasuyoshi Morita, Hirokazu Tanaka, 2018, Internal medicine.

Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells

I. Matsumura, Yasuyoshi Morita, C. Hirase, 2022, British journal of haematology.

Aberrant expression of immunoglobulin light chain isotype in B lymphocytes from patients with monoclonal gammopathies: isotypic discordance and clonal B‐cell excess

I. Matsumura, K. Oritani, S. Tarui, 1990, British journal of haematology.

Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents

K. Ohta, M. Taniwaki, M. Hino, 2014, International Journal of Hematology.

Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.

I. Matsumura, Ayumi Matsumoto, Hirokazu Tanaka, 2018, Cancer letters.

Necessity of tyrosine 719 and phosphatidylinositol 3'-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation.

Y. Kitamura, I. Matsumura, K. Hashimoto, 2003, Blood.

Establishment and characterization of a new human B‐cell line (ONHL‐1) from non‐Hodgkin's lymphoma: Constant expression of bcl‐2 gene during mitogen‐induced growth inhibition

M. Taniwaki, I. Matsumura, K. Oritani, 1990, International journal of cancer.

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis

K. Ohta, J. Kanda, M. Hino, 2022, Therapeutic advances in hematology.

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

M. Hino, K. Ishizawa, I. Matsumura, 2022, International Journal of Hematology.

Multiple cytokine-producing B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma with autoimmune hemolytic anemia

I. Matsumura, Yasuyoshi Morita, Shinya Rai, 2019, Leukemia & lymphoma.

A decision analysis for unrelated bone marrow transplantation or immediate cord blood transplantation for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission: Unrelated BMT or immediate CBT for Ph-negative ALL.

J. Kanda, S. Kako, Y. Kanda, 2021, Transplantation and cellular therapy.

Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis

K. Ohta, J. Kanda, M. Hino, 2021, European journal of haematology.

Induction of Complete Remission by Azacitidine in a Patient with Myelodysplastic Syndrome-Associated Inflammatory Bowel Disease.

M. Kudo, S. Hagiwara, Y. Komeda, 2018, Journal of Crohn's & colitis.

U-KIM-1 as a predictor of treatment response in lupus nephritis

I. Matsumura, K. Kinoshita, Y. Nozaki, 2022, Lupus.

Cellulitis with Leukocytopenia as an Initial Sign of Acute Promyelocytic Leukemia

A. Kawada, I. Matsumura, N. Oiso, 2012, Case Reports in Dermatology.

Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide

K. Ohta, J. Kanda, T. Matsui, 2022, Therapeutic advances in hematology.

Antifungal Activity of Micafungin in Serum

I. Matsumura, J. Ishikawa, Y. Kanakura, 2009, Antimicrobial Agents and Chemotherapy.

C-type lectin-like receptor 2 specifies a functionally distinct subpopulation within phenotypically defined hematopoietic stem cell population that contribute to emergent megakaryopoiesis

I. Matsumura, Yasuyoshi Morita, Y. Taniguchi, 2022, International Journal of Hematology.

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study

M. Kizaki, K. Ozawa, K. Mitani, 2020, British journal of haematology.

Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine‐dependent growth of hematopoietic cells

Itaru Matsumura, Julian Downward, Chris Albanese, 1999, The EMBO journal.

E2F1 and c-Myc in Cell Growth and Death

Itaru Matsumura, I. Matsumura, Y. Kanakura, 2003, Cell cycle.

Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.

Chunaram Choudhary, W. Berdel, H. Serve, 2003, Blood.

Stimulation of 3T3-L1 adipogenesis by signal transducer and activator of transcription 5.

Y. Masuho, I. Matsumura, H. Wakao, 2002, Molecular endocrinology.

Roles for Signaling Molecules in the Growth and Survival of CML Cells

I. Matsumura, 2016 .

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases

A. Yeoh, Yuan-fang Liu, Saijuan Chen, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells*

I. Matsumura, Y. Kanakura, Eriko Ishiko, 2004, Journal of Biological Chemistry.

Foxp3-Positive Regulatory T Cells Contribute to Antifibrotic Effects in Renal Fibrosis via an Interleukin-18 Receptor Signaling Pathway

I. Matsumura, A. Inoue, K. Kinoshita, 2020, Frontiers in Medicine.

Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.

Y. Matsuzawa, H. Kitayama, K. Yamamura, 1996, Blood.

Cell cycle regulation in hematopoietic stem/progenitor cells.

Itaru Matsumura, I. Matsumura, Y. Kanakura, 2004, Cell cycle.

SFRP1 Is Estrogen Inducible in Bone Marrow Stromal Cells and Suppresses the Earliest Events in Lymphopoiesis.

K. Garrett, M. Nishida, I. Matsumura, 2007 .

[Immune evasion of Pseudomonas aeruginosa].

I. Matsumura, Takahiro Shimada, 2014, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination.

C. Albanese, R. Pestell, T. Sakamaki, 2002, Molecular cell.

Both Stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6-induced apoptosis of 1A9-M cells.

Y. Matsuzawa, T. Hirano, I. Matsumura, 1999, Blood.

Both Stat 3-Activation and Stat 3-Independent BCL 2 Downregulation Are Important for Interleukin-6 – Induced Apoptosis of 1 A 9M Cells

Y. Matsuzawa, T. Hirano, I. Matsumura, 1999 .

The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.

T. Miyata, I. Matsumura, Y. Kanakura, 2013, Immunity.

Clathrin Assembly Protein CALM Plays a Critical Role in KIT Signaling by Regulating Its Cellular Transport from Early to Late Endosomes in Hematopoietic Cells

Itaru Matsumura, Takahiro Shimada, Akira Tanimura, 2014, PloS one.

[Reviews] Pathogenetic and clinical significance of genetic abnormalities in acute myeloid leukemia

I. Matsumura, 2010 .

Integrin-associated protein/CD47 regulates motile activity in human B-cell lines through CDC42.

Y. Matsuzawa, Y. Okajima, I. Matsumura, 2000, Blood.

BCR-ABL but Not JAK2 V617F Inhibits Erythropoiesis through the Ras Signal by Inducing p21CIP1/WAF1*

I. Matsumura, Y. Kanakura, K. Oritani, 2010, The Journal of Biological Chemistry.

Opposing effects of PML and PML/RAR alpha on STAT3 activity.

A. Kawasaki, I. Matsumura, Y. Kanakura, 2003, Blood.

Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection

I. Matsumura, Y. Maeda, Yasuyoshi Morita, 2012, Hematology.

Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis.

H. Nakamine, T. Yoshino, I. Matsumura, 2016, Journal of clinical and experimental hematopathology : JCEH.

Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis

E. Morii, Y. Kitamura, I. Matsumura, 2004, The Journal of experimental medicine.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Francisco Cervantes, Ryuzo Ohno, Richard E. Clark, 2013, Blood.

Molecular Control of Megakaryopoiesis and Thrombopoiesis

I. Matsumura, Y. Kanakura, 2002, International journal of hematology.

A case of intraocular lymphoma with central nervous system involvement and high interleukin-10 levels in both vitreous humor and cerebrospinal fluids: successful treatment with a combination of intravitreal, intrathecal, and systemic therapy

I. Matsumura, Y. Maeda, Yasuyoshi Morita, 2013, International Cancer Conference Journal.

Diffuse large B cell lymphoma with an interfollicular pattern of proliferation shows a favourable prognosis: a study of the Osaka Lymphoma Study Group

M. Hino, E. Morii, K. Aozasa, 2012, Histopathology.

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial

Y. Kanda, I. Matsumura, H. Shibayama, 2021, International Journal of Hematology.

Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.

T. Kaisho, H. Kitayama, Y. Kitamura, 1999, Blood.

Constitutive Activation of C-kit by the Juxtamembrane but Not the Catalytic Domain Mutations Is Inhibited Selectively by Tyrosine Kinase Inhibitors STI571 and AG1296

I. Matsumura, Y. Kanakura, M. Mizuki, 2002, International journal of hematology.

Validation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale

T. Naoe, I. Matsumura, Y. Kanakura, 2016, SpringerPlus.

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

T. Naoe, Y. Shiraishi, K. Chiba, 2017, Blood Cancer Journal.

Excessive Reactive Iron Impairs Hematopoiesis by Affecting Both Immature Hematopoietic Cells and Stromal Cells

I. Matsumura, Y. Kanakura, Yasuyoshi Morita, 2019, Cells.

Multiple cytokine-producing aggressive EBV-positive diffuse large B cell lymphoma, not otherwise specified with hemophagocytic syndrome

I. Matsumura, Yasuyoshi Morita, Y. Taniguchi, 2019, Annals of Hematology.

Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial

K. Akashi, N. Kadowaki, T. Miyamoto, 2016 .

Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib

T. Kyo, I. Matsumura, T. Tauchi, 2012, British journal of haematology.

Oncogenic receptor tyrosine kinase in leukemia.

H. Serve, I. Matsumura, Y. Kanakura, 2003, Cellular and molecular biology.

AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells*

T. Era, I. Matsumura, Y. Kanakura, 2008, Journal of Biological Chemistry.

NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells.

M. McBurney, I. Matsumura, Y. Kanakura, 2006, Biochemical and biophysical research communications.

Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma

I. Matsumura, Y. Hoshida, Y. Maeda, 2013, Leukemia & lymphoma.

Lipopolysaccharide-Induced Acute Kidney Injury Is Dependent on an IL-18 Receptor Signaling Pathway

I. Matsumura, Y. Nozaki, M. Funauchi, 2017, International journal of molecular sciences.

Reciprocal Inhibition between MyoD and STAT3 in the Regulation of Growth and Differentiation of Myoblasts*

A. Kawasaki, T. Yokota, I. Matsumura, 2003, Journal of Biological Chemistry.

FDG-PET/CT and Auricular Cartilage Biopsy Are Useful for Diagnosing with Relapsing Polychondritis in Patients without Auricular Symptoms

I. Matsumura, K. Kinoshita, Y. Nozaki, 2021, Life.

Usefulness of dermoscopy-aided skin biopsy for clinically recognizable intravascular large B-cell lymphoma: prediction of histopathological localization of occlusive vessels based on dermoscopic findings

A. Kawada, I. Matsumura, N. Oiso, 2020, European Journal of Dermatology.

Intravascular Lymphoma Presenting as a Cavernous Sinus Tumor

A. Kato, S. Kusunoki, I. Matsumura, 2019, Internal medicine.

Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group

M. Hino, E. Morii, K. Aozasa, 2011, Journal of hematology & oncology.

Tumour‐immune microenvironment in duodenal‐type follicular lymphoma

I. Matsumura, Yasuyoshi Morita, Y. Taniguchi, 2020, British journal of haematology.

GATA Transcription Factors Inhibit Cytokine-dependent Growth and Survival of a Hematopoietic Cell Line through the Inhibition of STAT3 Activity*

T. Enver, Satoru Takahashi, Masayuki Yamamoto, 2005, Journal of Biological Chemistry.

Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines

A. Kawasaki, Masayuki Yamamoto, I. Matsumura, 2000 .

Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.

I. Matsumura, S. Hashimoto, S. Nakayama, 2018, Platelets.

GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins.

T. Enver, K. Ishihara, Masayuki Yamamoto, 2002, Blood.

Constitutively Activated Rho Guanosine Triphosphatases Regulate the Growth and Morphology of Hairy Cell Leukemia Cells

A. Kawasaki, I. Matsumura, Y. Kanakura, 2003, International journal of hematology.

Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study

T. Naoe, N. Takahashi, K. Togitani, 2018, International Journal of Hematology.

Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy.

I. Matsumura, H. Murota, I. Katayama, 2009, Journal of the American Academy of Dermatology.

Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma

I. Matsumura, S. Hashimoto, S. Nakayama, 2018, Annals of Hematology.

Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3‐internal tandem duplication AML: The JALSG AML209‐FLT3‐SCT study

T. Naoe, Y. Ishikawa, H. Matsuoka, 2020, Cancer Science.

Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma

K. Nishio, I. Matsumura, K. Sakai, 2021, Cancer science.

Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial

I. Matsumura, Y. Maeda, Yasuyoshi Morita, 2021, International Journal of Hematology.

Lenalidomide and low‐dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study

M. Taniwaki, S. Iida, T. Uchida, 2016, Cancer science.

Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma

K. Ohta, M. Taniwaki, J. Kuroda, 2014, International Journal of Hematology.

Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study

T. Naoe, I. Matsumura, Y. Miyazaki, 2018, Leukemia.

Two consecutive pregnancies in a patient with paroxysmal nocturnal haemoglobinuria treated with anticoagulant therapy at different doses.

I. Matsumura, Y. Kanakura, T. Tomimatsu, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Successful anticoagulant therapy for two pregnant PNH patients, and prospects for the eculizumab era

I. Matsumura, Y. Kanakura, Yasuyoshi Morita, 2013, International Journal of Hematology.

Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma

K. Ohta, J. Kanda, M. Hino, 2021, Hematological oncology.

Effects of tamibarotene for the treatment of adult T cell leukemia

I. Matsumura, Y. Maeda, C. Hirase, 2012, Annals of Hematology.

Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study

K. Akashi, K. Takenaka, A. Gotoh, 2021, International Journal of Hematology.

The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.

I. Matsumura, Y. Kanakura, H. Ikeda, 1996, Leukemia & lymphoma.

The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.

Y. Matsuzawa, H. Kitayama, H. Miyazaki, 1996, Blood.

High-affinity interleukin 2 receptors on B cell chronic lymphocytic leukemia cells are induced by phorbol myristate acetate but not by calcium ionophore.

I. Matsumura, Y. Kanakura, S. Tarui, 1991, Immunology letters.

FIP1L1-PDGFRα Imposes Eosinophil Lineage Commitment on Hematopoietic Stem/Progenitor Cells*

A. Iwama, I. Matsumura, Y. Kanakura, 2009, Journal of Biological Chemistry.

Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant

H. Serve, I. Matsumura, Y. Kanakura, 2005, Oncogene.

Suppressor of cytokine signalling‐1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines

M. Emi, H. Kanegane, I. Kawase, 2004, British journal of haematology.

Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report

M. Kudo, S. Hagiwara, Y. Komeda, 2020, World journal of clinical cases.

GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1.

T. Hirano, I. Matsumura, H. Yoshida, 2000, Blood.

Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry

K. Ohta, J. Kanda, M. Hino, 2020, International Journal of Hematology.

C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells

I. Matsumura, Y. Kanakura, M. Mizuki, 2012, Leukemia.

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial

Y. Kanda, I. Matsumura, C. Nakaseko, 2018, International Journal of Hematology.

Efficacy of iguratimod vs. salazosulfapyridine as the first-line csDMARD for rheumatoid arthritis

I. Matsumura, A. Inoue, K. Kinoshita, 2020, Modern rheumatology.

Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan

T. Miyamoto, K. Ishizawa, I. Matsumura, 2019, In Vivo.

Localised giant haematoma and subsequent widespread purpura as a sign of acquired haemophilia A

A. Kawada, I. Matsumura, N. Oiso, 2013, The Australasian journal of dermatology.

Mosaicism of an ELANE Mutation in an Asymptomatic Mother in a Familial Case of Cyclic Neutropenia

O. Ohara, I. Matsumura, S. Okada, 2015, Journal of Clinical Immunology.

Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines.

A. Kawasaki, I. Matsumura, Y. Kanakura, 2000, Blood.

HIV-negative Primary Bone Marrow Hodgkin Lymphoma Manifesting with a High Fever Associated with Hemophagocytosis as the Initial Symptom: A Case Report and Review of the Previous Literature.

I. Matsumura, Masafumi Ito, Yasuyoshi Morita, 2015, Internal medicine.

EBF1–JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity

S. Tsuzuki, M. Sanada, T. Yasuda, 2023, International Journal of Hematology.

Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP‐IGH fusion gene

S. Tsuzuki, M. Sanada, T. Yasuda, 2022, Cancer science.

Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.

T. Naoe, S. Tsuzuki, Y. Shiraishi, 2021, Blood.

Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study

T. Naoe, S. Ogawa, Y. Ishikawa, 2018, Annals of Hematology.

Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study

H. Matsuoka, K. Kirito, I. Matsumura, 2022, Cancer medicine.

Clinical outcomes of second‐generation tyrosine kinase inhibitors versus imatinib in older patients with CML

T. Naoe, R. Suzuki, M. Kizaki, 2022, Cancer science.

Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor

T. Naoe, R. Suzuki, M. Kizaki, 2020, Cancer science.

Risk Stratified Therapy with Nelarabine and Intensified Administration of L-Asparaginase for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults (JPLSG T-11/JALSG T-ALL-211-U): An Intergroup Phase 2 Study

J. Kanda, K. Horibe, I. Matsumura, 2022, Blood.

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment

I. Matsumura, K. Kinoshita, Y. Nozaki, 2021, Frontiers in Endocrinology.

Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.

K. Horibe, T. Imamura, N. Kiyokawa, 2023, The Lancet. Haematology.

Efficacy and Safety of Tyrosine Kinase Inhibitors for Treatment of Newly Diagnosed Chronic Myeloid Leukemia: Results Using Data Obtained with the New Target System from the Japanese Registry

K. Akashi, T. Naoe, R. Suzuki, 2018, Blood.

Deletion of Antigen-Presenting Cells in Lipopolysaccharide-Induced Acute Kidney Injury (AKI) Affects the Exacerbation and Repair in AKI

I. Matsumura, K. Kinoshita, Y. Nozaki, 2022, Current issues in molecular biology.

Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.

T. Yano, I. Matsumura, K. Kinoshita, 2015, American journal of physiology. Renal physiology.

Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis

T. Yano, I. Matsumura, K. Kinoshita, 2014, Lupus.

Potent efficacy of chlorpromazine in acute myeloid leukemia harboring KIT-D816V mutation

I. Matsumura, Shinya Rai, Hirokazu Tanaka, 2021, Leukemia research reports.

The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis.

I. Matsumura, Y. Kanakura, K. Oritani, 2014, Experimental hematology.

PICOT is a molecule which binds to anamorsin.

I. Matsumura, Y. Kanakura, Akira Tanimura, 2011, Biochemical and biophysical research communications.

The expression of anamorsin in diffuse large B cell lymphoma: Possible prognostic biomarker for low IPI patients

M. Hino, K. Aozasa, H. Ogawa, 2008, Leukemia & lymphoma.

Allogeneic HSCT at the first remission for younger adults with FLT3-ITD AML: The JALSG AML209-FLT3-SCT Study.

T. Naoe, Y. Ishikawa, H. Matsuoka, 2020, Cancer Science.

Targeted therapy for medullary and extramedullary relapse of FLT3-ITD acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation

I. Matsumura, Yasuyoshi Morita, Y. Taniguchi, 2020, Leukemia research reports.

SIRT1 Deficiency Suppresses the Maintenance of Hematopoietic Stem Cell Pool.

I. Matsumura, Y. Kanakura, K. Oritani, 2008 .

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality

I. Matsumura, Yasuyoshi Morita, Shinya Rai, 2019, Front. Immunol..

Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry

K. Ohta, J. Kanda, T. Matsui, 2020, International Journal of Hematology.

A Global, Randomized, Placebo-Controlled, Phase 3 Study of Ibrutinib Plus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (RCHOP) in Patients with Previously Untreated Non-Germinal Center B-Cell-like (GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

L. Staudt, W. Wilson, L. Sehn, 2018, Blood.

Revised MS M 4 : 00407 Roles for c-Myc in self-renewal of hematopoietic stem cells

I. Matsumura, Y. Kanakura, Eriko Ishiko, 2004 .

Aleukemic solitary cutaneous myeloid sarcoma

H. Nakamine, A. Kawada, I. Matsumura, 2015, The Journal of dermatology.

A case of chronic myelomonocytic leukemia who developed pericardial effusion during stably controlled leukocytosis.

I. Matsumura, Y. Maeda, Yasuyoshi Morita, 2011, Internal medicine.

Phase 1/2 study evaluating the safety and efficacy of DSP‐7888 dosing emulsion in myelodysplastic syndromes

H. Iwasaki, T. Naoe, M. Kizaki, 2021, Cancer science.

[Pathogenesis of anemia of chronic disease].

I. Matsumura, Y. Kanakura, 2008, Nihon rinsho. Japanese journal of clinical medicine.

Nilotinib Vs. Dasatinib in Achieving MR4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

T. Naoe, T. Miyamoto, N. Takahashi, 2020 .

Tumor necrosis factor- and interleukin-6-producing high-grade B-cell lymphoma, not otherwise specified in the pleura

I. Matsumura, K. Kawahara, S. Hashimoto, 2018, Leukemia Research Reports.

High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study

Y. Ishikawa, S. Kako, I. Matsumura, 2023, HemaSphere.

Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial

T. Naoe, S. Horiike, T. Yamauchi, 2022, International Journal of Hematology.

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

I. Matsumura, Yasuyoshi Morita, Y. Taniguchi, 2023, Journal of clinical and experimental hematopathology : JCEH.

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

I. Matsumura, A. Inoue, K. Kinoshita, 2018, Biologics : targets & therapy.

Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis

I. Matsumura, T. Hidaka, K. Kinoshita, 2021, Frontiers in Medicine.

Decreased nitric oxide‐mediated natural killer cell activation in chronic fatigue syndrome

Tomiyama, Y. Okajima, I. Matsumura, 1998, European journal of clinical investigation.

The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.

T. Miyata, I. Matsumura, Y. Kanakura, 2013, Immunity.

Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma: Current Understanding and Differential Diagnosis.

H. Nakamine, T. Yoshino, I. Matsumura, 2016, Journal of clinical and experimental hematopathology : JCEH.

I. Matsumura, Yasuyoshi Morita, Shinya Rai, 2013, Internal medicine.

Signaling through the interleukin-18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury.

T. Yano, I. Matsumura, K. Kinoshita, 2012, Kidney international.

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

J. Radich, H. Kantarjian, D. B. Yehuda, 2013, Blood.

Final Results From SENSOR: Switch to Nilotinib After Molecular Suboptimal Response (SoR) to Frontline Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

M. Taniwaki, M. Tanimoto, T. Miyamoto, 2014 .

Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes

M. Tomonaga, K. Ozawa, Y. Niitsu, 2008, International journal of hematology.

Mice doubly‐deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality

Y. Matsui, N. Tanuma, H. Shima, 2015, FEBS letters.

BCR-ABL but Not JAK2 V617F Inhibits Erythropoiesis through the Ras Signal by Inducing p21CIP1/WAF1*

I. Matsumura, Y. Kanakura, K. Oritani, 2010, The Journal of Biological Chemistry.

Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum

K. Ohta, J. Kuroda, I. Matsumura, 2023, Leukemia research reports.

PICOT is a molecule which binds to anamorsin.

I. Matsumura, Y. Kanakura, Akira Tanimura, 2011, Biochemical and biophysical research communications.

Endogenous Tim-1 promotes severe systemic autoimmunity and renal disease MRL-Fas(lpr) mice.

I. Matsumura, H. Yagita, H. Akiba, 2014, American journal of physiology. Renal physiology.

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab

I. Matsumura, N. Nakamura, Yasuyoshi Morita, 2018, Cancers.

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

Jason J. Z. Liao, H. Iwasaki, S. Iida, 2020, International Journal of Hematology.